MATHILDE KINGE-RASMUSSEN

B. 1989 | 1358 JAR

Roles

Share Ownership

Direct Ownership

5.88%(5)5 shares

KINGE HOLDING AS

0.03%(13850)13850 shares

VISTIN PHARMA ASA

Indirect Ownership

3.53%

SANDVIKA NEVROSENTER -

1.76%

SANDVIKA NEVROSENTER -

0.23%

NORDIC BRAIN TECH AS

0.07%

HIGH YIELD PROPERTY AS

0.05%

0.03%

VISTIN PHARMA AS

0.01%

DEAS NORWAY BALANCED

0.01%

SWISS LIFE REF NORDIC 2018

Home Industries New Companies About

🇳🇴Norsk 🇬🇧English